These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12050679)

  • 1. [FISH diagnostics].
    Sápi Z; Bodó M
    Magy Onkol; 2002; 46(1):25-32. PubMed ID: 12050679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
    Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
    Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From "monocolor" karyotype to "multicolor" karyotype: applications of M-Fish in hematology and oncology].
    Jaffray JY; Giollant M; Perissel B; Vago P
    Bull Cancer; 2002 Feb; 89(2):174-80. PubMed ID: 11888857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FISH in cancer diagnosis and prognostication: from cause to course of disease.
    Weier HU; Greulich-Bode KM; Ito Y; Lersch RA; Fung J
    Expert Rev Mol Diagn; 2002 Mar; 2(2):109-19. PubMed ID: 11962331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
    Sanjmyatav J; Schubert J; Junker K
    Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
    Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
    Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening?
    Panani AD; Kozirakis D; Anastasiou J; Babanaraki A; Malovrouvas D; Roussos C
    Anticancer Res; 2006; 26(2A):1161-5. PubMed ID: 16619518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
    Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
    Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
    Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization.
    Sanjmyatav J; Rubtsov N; Starke H; Schubert J; Hindermann W; Junker K
    J Urol; 2005 Aug; 174(2):731-5. PubMed ID: 16006966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
    Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
    Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors.
    Nilsson M; Höglund M; Panagopoulos I; Sciot R; Dal Cin P; Debiec-Rychter M; Mertens F; Mandahl N
    Virchows Arch; 2002 Nov; 441(5):475-80. PubMed ID: 12447678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
    Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
    Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase FISH as a new tool in tumor pathology.
    Tibiletti MG
    Cytogenet Genome Res; 2007; 118(2-4):229-36. PubMed ID: 18000375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delineating a supernumerary marker chromosome by combining several cytogenetic and molecular cytogenetic techniques].
    Tan YQ; Di YF; Song YZ; Cheng DH; Li LY; Lu GX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):392-6. PubMed ID: 17680527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.